Pathological α-synuclein transmission initiated by binding lymphocyte-activation gene 3

Abstract

INTRODUCTION Parkinson’s disease (PD) is the second most common neurodegenerative disorder that leads to slowness of movement, tremor, rigidity and in the later stages of PD, cognitive impairment. Pathologically PD is characterized by the accumulation of α-synuclein in Lewy bodies and neurites. There is degeneration of neurons throughout the nervous system with the degeneration of dopamine neurons in the substantia nigra pars compacta leading to the major symptoms of PD. RATIONALE In the brains of PD patients, pathologic α-synuclein seems to spread from cell-to-cell via self-amplification, propagation, and transmission in a stereotypical and topographical pattern among neighboring cells and/or anatomically connected brain regions. The spread or transmission of pathologic α-synuclein is emerging as potentially important driver of PD pathogenesis. The underlying mechanisms and molecular entities responsible for the transmission of pathologic α-synuclein from cell-to-to cell are not known, but the entry of pathologic α-synuclein into neurons is thought to occur, in part through an active clathrin-dependent endocytic process. RESULTS Using recombinant α-synuclein pre-formed fibrils (PFF) as a model system to study the transmission of misfolded α-synuclein from neuron to neuron, we screened a library encoding transmembrane proteins for α-synuclein-biotin PFF binding candidates via detection by streptavidin-AP (alkaline phosphatase) staining. Three positive clones were identified that bind α-synuclein PFF and include lymphocyte-activation gene 3 (LAG3), neurexin 1β and amyloid beta precursor-like protein 1 (APLP1). Of these three transmembrane proteins, LAG3 demonstrated the highest ratio of selectivity for α-synuclein PFF over the α-synuclein monomer. α-Synuclein PFF binds to LAG3 in a saturable manner (Kd = 77 nM), while the α-synuclein monomer does not bind to LAG3. Co-immunoprecipitation also suggests that pathological α-synuclein PFF specifically binds to LAG3. Tau PFF, β-amyloid oligomer and β-amyloid PFF do not bind LAG3 indicating that LAG3 is specific for α-synuclein PFF. The internalization of α-synuclein PFF involves LAG3 since deletion of LAG3 reduces the endocytosis of α-synuclein PFF. LAG3 colocalizes with the endosomal GTPases, Rab5 and Rab7 and co-endocytoses with pathologic α-synuclein. Neuron-to-neuron transmission of pathologic α-synuclein and the accompanying pathology and neurotoxicity is substantially attenuated by deletion of LAG3 or by LAG3 antibodies. The lack of LAG3 also substantially delayed α-synuclein PFF induced loss of dopamine neurons, as well as biochemical and behavioral deficits in vivo. CONCLUSION We discovered that pathologic α-synuclein transmission and toxicity is initiated by binding to LAG3 and that neuron-to-neuron transmission of pathological α-synuclein involves the endocytosis of exogenous α-synuclein PFF by the engagement of LAG3 on neurons. Depletion of LAG3 or antibodies to LAG3 substantially reduce the pathology set in motion by the transmission of pathologic α-...

Selective imaging of internalized proteopathic α-synuclein seeds in primary neurons reveals mechanistic insight into transmission of synucleinopathies

“…proteolytic degradation, endocytic escape, trafficking to recycling endosomes, etc.). The recent report of LAG3 as a putative receptor for ␣-syn uptake is compelling, although multiple receptors or transmission mechanisms for ␣-syn aggregate internalization are possible (58). For example, it has been demonstrated via flow cytometry that macropinocytotic uptake of both ␣-syn and Tau by immortalized cells and primary neurons is mediated by HSPGs (11).…”

Hallmarks of Brain Aging: Adaptive and Pathological Modification by Metabolic States

“…Lysosome dysfunction and oxidative stress can trigger the release of EVs containing aggregating α-synuclein, and those EVs can then be internalized and trigger the accumulation of toxic α-synuclein aggregates in previously healthy neurons (Emmanouilidou et al, 2010; Poehler et al, 2014; Zhang et al, 2018). Another potential mechanism for spreading of α-synuclein pathology is suggested by a study showing that misfolded preformed fibrils bind to LAG3 (lymphocyte-activation gene 3) and that LAG3 initiates α-synuclein preformed fibril endocytosis, transmission, and cytotoxicity (Mao et al, 2016). …”

Membrane Trafficking Illuminates a Path to Parkinson’s Disease

“…In this regard, toll-like receptor 2 (TLR2) in neuron and microglial cells could serve as the receptor for extracellular αSYN oligomers (Kim et al 2013). Furthermore, a recent study has identified the lymphocyte-activation gene 3 (LAG3), also known as CD223, as the binding partner for preformed αSYN fibrils (Mao et al 2016). The LAG3 expressed on neurons may serve as a putative receptor for extracellular αSYN fibrils, leading to their endocytosis.…”